» Articles » PMID: 33416199

Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye-Tracking Study

Overview
Journal Mov Disord
Date 2021 Jan 8
PMID 33416199
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The pathophysiology of cervical dystonia is still unclear. Recent evidence points toward a network disorder affecting several brain areas. The objective of this study was to assess the saccadic inhibition as a marker of corticostriatal function in cervical dystonia.

Methods: We recruited 31 cervical dystonia patients and 17 matched healthy controls. Subjects performed an overlap prosaccade, an antisaccade, and a countermanding task on an eye tracker to assess automatic visual response and response inhibition.

Results: Cervical dystonia patients made more premature saccades (P = 0.041) in the overlap prosaccade task and more directional errors in the antisaccade task (P = 0.011) and had a higher rate of failed inhibition in the countermanding task (P = 0.001).

Conclusions: The results suggest altered saccadic inhibition in cervical dystonia, possibly as a consequence of dysfunctional corticostriatal networks. Further studies are warranted to confirm whether these abnormalities are affected by the available therapies and whether this type of impairment is found in other focal dystonias. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Citing Articles

Memory-Guided Saccades and Non-Motor Symptoms Improve after Botulinum Toxin Therapy in Cervical Dystonia.

Gilman Kuric T, Popovic Z, Matosa S, Sadikov A, Groznik V, Georgiev D J Clin Med. 2024; 13(19).

PMID: 39407768 PMC: 11477116. DOI: 10.3390/jcm13195708.


Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking.

Carbone F, Zamarian L, Rass V, Bair S, Ritter M, Beer R Ann Clin Transl Neurol. 2022; 9(11):1826-1831.

PMID: 36264758 PMC: 9639623. DOI: 10.1002/acn3.51675.


Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study.

Ellmerer P, Peball M, Carbone F, Ritter M, Heim B, Marini K Brain Sci. 2022; 12(5).

PMID: 35625047 PMC: 9139535. DOI: 10.3390/brainsci12050661.

References
1.
Xu K, Anderson B, Emeric E, Sali A, Stuphorn V, Yantis S . Neural Basis of Cognitive Control over Movement Inhibition: Human fMRI and Primate Electrophysiology Evidence. Neuron. 2017; 96(6):1447-1458.e6. PMC: 5747365. DOI: 10.1016/j.neuron.2017.11.010. View

2.
Desrochers P, Brunfeldt A, Sidiropoulos C, Kagerer F . Sensorimotor Control in Dystonia. Brain Sci. 2019; 9(4). PMC: 6523253. DOI: 10.3390/brainsci9040079. View

3.
Reuter B, Rakusan L, Kathmanna N . Poor antisaccade performance in schizophrenia: an inhibition deficit?. Psychiatry Res. 2005; 135(1):1-10. DOI: 10.1016/j.psychres.2004.12.006. View

4.
Romano R, Bertolino A, Gigante A, Martino D, Livrea P, Defazio G . Impaired cognitive functions in adult-onset primary cranial cervical dystonia. Parkinsonism Relat Disord. 2013; 20(2):162-5. DOI: 10.1016/j.parkreldis.2013.10.008. View

5.
Allam N, Frank J, Pereira C, Tomaz C . Sustained attention in cranial dystonia patients treated with botulinum toxin. Acta Neurol Scand. 2007; 116(3):196-200. DOI: 10.1111/j.1600-0404.2007.00862.x. View